•  
  •  
  •  
  •  

2025-10-07 15:49:17

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Biocon Pharma Ltd in partnership with Carnegie Pharmaceuticals LLC receives USFDA tentative approval for Rifaximin Tablets
  • Revolt Motors fuels India's Racing Future with Sponsorship of Young Racer Ethan Joy at F4 India Championship
  • Simplex Realty Limited enters into supplemental agreement for redevelopment project
  • Ameenji Rubber Ltd. debuts on BSE SME Exchange
  • Mahanagar Gas Ltd signs MoU with Oil India Ltd to collaborate across the LNG value chain

Keywords Selected:  Nureca

Stock Report

  • Nureca Ltd posts Rs. 81.3 lakhs PAT in Q1 FY26
  • Nureca Ltd consolidated Q4 FY2025 net profit at Rs. 2.46 crore
  • Nureca Limited expands Quick Commerce reach with Dr Trust products now available on Swiggy Instamart
  • Nureca Ltd receives approval for new manufacturing facility
  • Nureca Limited's products to be available on Swiggy Instamart soon
  • Nureca Limited's Manufacturing Subsidiary Secures US FDA Registration
  • Nureca Ltd board approves expansion plan
  • Nureca Ltd posts consolidated Q3FY25 loss of Rs. 2.80 crores
  • Nureca appoints Vivek Gupta as Chief Officer Sales and Supply Chain
  • Nureca Limited Certified as a Great Place to Work
  • Nureca Ltd Q2 FY2025 consolidated loss at Rs. 48.2 lakhs
  • Nureca Ltd Q1 FY25 consolidated net profit at Rs. 1.66 crore
  • Nureca Ltd posts consolidated Q4 FY24 loss at Rs. 4.14 crore
  • Nureca Limited's Dr Trust recognized as a 'Well Known Trademark' by the Indian Trademark Registry
  • Dr Trust ranked No.1 in India's Top Home Healthcare & Wellness Brand
  • Nureca Ltd consolidated Q2FY24 PAT at Rs. 2.89 crore
  • Nureca Ltd Q4FY23 consolidated loss at Rs. 1.53 crore
  • Nureca Ltd Q3 FY2023 consolidated net profit at Rs. 30.1 lakhs
  • Nureca Ltd consolidated Q4 FY2021-22 loss at Rs. 1.40 crore
  • Nureca Limited announces resignation of Mr. Sushil Kumar Bhardwaj
  • Nureca Ltd Board declares Interim Dividend of Rs. 3

Latest Post

  • Biocon Pharma Ltd in partnership with Carnegie Pharmaceuticals LLC receives USFDA tentative approval for Rifaximin Tablets
  • Revolt Motors fuels India's Racing Future with Sponsorship of Young Racer Ethan Joy at F4 India Championship
  • Simplex Realty Limited enters into supplemental agreement for redevelopment project
  • Ameenji Rubber Ltd. debuts on BSE SME Exchange
  • Mahanagar Gas Ltd signs MoU with Oil India Ltd to collaborate across the LNG value chain


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024